303 related articles for article (PubMed ID: 9660366)
41. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.
Chun TW; Stuyver L; Mizell SB; Ehler LA; Mican JA; Baseler M; Lloyd AL; Nowak MA; Fauci AS
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13193-7. PubMed ID: 9371822
[TBL] [Abstract][Full Text] [Related]
42. HIV-1: towards understanding the nature and quantifying the latent reservoir.
Chatzidimitriou D; Tsotridou E; Grigoropoulos P; Skoura L
Acta Virol; 2020; 64(1):3-9. PubMed ID: 32180413
[TBL] [Abstract][Full Text] [Related]
43. Tracking replication-competent HIV reservoirs in infected individuals.
Chun TW
Curr Opin HIV AIDS; 2013 Mar; 8(2):111-6. PubMed ID: 23380652
[TBL] [Abstract][Full Text] [Related]
44. [Cell and tissue reservoirs of HIV-1: dynamics during infection].
Trémeaux P; Rouzioux C; Avettand-Fènoël V
Virologie (Montrouge); 2019 Aug; 23(4):211-228. PubMed ID: 31414659
[TBL] [Abstract][Full Text] [Related]
45. HIV Persistence on Antiretroviral Therapy and Barriers to a Cure.
Sung JM; Margolis DM
Adv Exp Med Biol; 2018; 1075():165-185. PubMed ID: 30030793
[TBL] [Abstract][Full Text] [Related]
46. Approaching eradication of highly active antiretroviral therapy-persistent human immunodeficiency virus type 1 reservoirs with immune activation therapy.
Kulkosky J; Pomerantz RJ
Clin Infect Dis; 2002 Dec; 35(12):1520-6. PubMed ID: 12471572
[TBL] [Abstract][Full Text] [Related]
47. Cell-to-Cell Spread of HIV and Viral Pathogenesis.
Law KM; Satija N; Esposito AM; Chen BK
Adv Virus Res; 2016; 95():43-85. PubMed ID: 27112280
[TBL] [Abstract][Full Text] [Related]
48. Reservoirs of HIV-1 in vivo: implications for antiretroviral therapy.
Saksena NK; Potter SJ
AIDS Rev; 2003; 5(1):3-18. PubMed ID: 12875103
[TBL] [Abstract][Full Text] [Related]
49. The challenge of viral reservoirs in HIV-1 infection.
Blankson JN; Persaud D; Siliciano RF
Annu Rev Med; 2002; 53():557-93. PubMed ID: 11818490
[TBL] [Abstract][Full Text] [Related]
50. Scientific rationale for antiretroviral therapy in 2005: viral reservoirs and resistance evolution.
Siliciano RF
Top HIV Med; 2005; 13(3):96-100. PubMed ID: 16170226
[TBL] [Abstract][Full Text] [Related]
51. Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.
Chun TW; Justement JS; Moir S; Hallahan CW; Maenza J; Mullins JI; Collier AC; Corey L; Fauci AS
J Infect Dis; 2007 Jun; 195(12):1762-4. PubMed ID: 17492591
[TBL] [Abstract][Full Text] [Related]
52. What can we do to reduce the viral reservoir in HIV-1-infected individuals?
Pohlmeyer CW; Walker-Sperling VE; Blankson JN
Future Microbiol; 2016 Jul; 11():839-42. PubMed ID: 27416850
[No Abstract] [Full Text] [Related]
53. Th1/17 Polarization of CD4 T Cells Supports HIV-1 Persistence during Antiretroviral Therapy.
Sun H; Kim D; Li X; Kiselinova M; Ouyang Z; Vandekerckhove L; Shang H; Rosenberg ES; Yu XG; Lichterfeld M
J Virol; 2015 Nov; 89(22):11284-93. PubMed ID: 26339043
[TBL] [Abstract][Full Text] [Related]
54. Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies.
Aquaro S; Svicher V; Schols D; Pollicita M; Antinori A; Balzarini J; Perno CF
J Leukoc Biol; 2006 Nov; 80(5):1103-10. PubMed ID: 16931601
[TBL] [Abstract][Full Text] [Related]
55. Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy.
Kulkosky J; Nunnari G; Otero M; Calarota S; Dornadula G; Zhang H; Malin A; Sullivan J; Xu Y; DeSimone J; Babinchak T; Stern J; Cavert W; Haase A; Pomerantz RJ
J Infect Dis; 2002 Nov; 186(10):1403-11. PubMed ID: 12404155
[TBL] [Abstract][Full Text] [Related]
56. A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy.
Araínga M; Edagwa B; Mosley RL; Poluektova LY; Gorantla S; Gendelman HE
Retrovirology; 2017 Mar; 14(1):17. PubMed ID: 28279181
[TBL] [Abstract][Full Text] [Related]
57. HIV-1 pathogenesis.
Stevenson M
Nat Med; 2003 Jul; 9(7):853-60. PubMed ID: 12835705
[TBL] [Abstract][Full Text] [Related]
58. HIV Persistence in Adipose Tissue Reservoirs.
Couturier J; Lewis DE
Curr HIV/AIDS Rep; 2018 Feb; 15(1):60-71. PubMed ID: 29423731
[TBL] [Abstract][Full Text] [Related]
59. HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes.
Redel L; Le Douce V; Cherrier T; Marban C; Janossy A; Aunis D; Van Lint C; Rohr O; Schwartz C
J Leukoc Biol; 2010 Apr; 87(4):575-88. PubMed ID: 19801499
[TBL] [Abstract][Full Text] [Related]
60. A Targeted Mass Spectrometry Assay for Detection of HIV Gag Protein Following Induction of Latent Viral Reservoirs.
Schlatzer D; Haqqani AA; Li X; Dobrowolski C; Chance MR; Tilton JC
Anal Chem; 2017 May; 89(10):5325-5332. PubMed ID: 28467046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
